Keros Therapeutics (KROS) has priced its initial public offering (IPO) of 6M common shares at $16.00/share, for gross proceeds of $96M.
Underwriters’ over-allotment is an additional 900,000 shares.
Closing date is April 13.
Trading kicks off today.
https://seekingalpha.com/news/3559243-keros-therapeutics-prices-ipo-16
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.